ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeiGene · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
locally advanced and metastatic solid tumors, bgb-a1217, anti-tigit antibody, tislelizumab, anti-pd-1 antibody, ociperlimab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 874942
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.